Avantax Advisory Services’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$418K	Buy	3,325 +1,213	+57%	+$152K	﹤0.01%	1690
2025 Q1	$234K	Sell	2,112 -783	-27%	-$86.6K	﹤0.01%	2006
2024 Q4	$395K	Buy	2,895 +297	+11%	+$40.5K	﹤0.01%	1601
2024 Q3	$299K	Sell	2,598 -201	-7%	-$23.2K	﹤0.01%	1752
2024 Q2	$385K	Buy	+2,799	New	+$385K	﹤0.01%	1540